In the published article, there was an error in the Funding statement. The Funding statement was not present in the original version. The correct Funding statement appears below.
“This work was financially supported by the National Natural Science Foundation of China (Award number(s): 81971194, 82171421, 91949118) and Science and Technology Commission of Shanghai Municipality (Award number(s): 2018SHZDZX01, 21S31902200); National Health Commission of the People’s Republic of China.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
Parkinson’s disease, Ginkgo biloba folium, Network pharmacolgy, deep learning, Single-nuclei RNA sequencing
Citation
Yan Y-C, Xu Z-H, Wang J and Yu W-B (2023) Corrigendum: Uncovering the pharmacology of Ginkgo biloba folium in the cell-type-specific targets of Parkinson’s disease with a deep learning algorithm. Front. Pharmacol. 13:1115043. doi: 10.3389/fphar.2022.1115043
Received
03 December 2022
Accepted
13 December 2022
Published
12 January 2023
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2022
Updates
Copyright
© 2023 Yan, Xu, Wang and Yu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jian Wang, wangjian_hs@fudan.edu.cn; Wen-Bo Yu, yuwenbo@fudan.edu.cn
This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.